Roger Geiger

Title: Roger Geiger: Innovator in T Cell Modulation

Introduction

Roger Geiger is a prominent inventor based in Bellinzona, Switzerland. He has made significant contributions to the field of immunotherapy, particularly in the modulation of T cell responses. His innovative work has the potential to advance therapeutic strategies for various diseases.

Latest Patents

Roger Geiger holds a patent titled "Arginine and its use as a T cell modulator." This invention provides novel uses and methods for T cell-based immunotherapies. Specifically, it relates to novel ligands, targets, and nucleic acids, as well as vectors encoding said targets that are useful for modulating T cell responses. He has 1 patent to his name.

Career Highlights

Geiger is affiliated with the Institute for Research in Biomedicine, where he conducts his research and development. His work focuses on enhancing the understanding of T cell modulation, which is crucial for improving immunotherapeutic approaches.

Collaborations

Roger Geiger has collaborated with notable scientists in his field, including Antonio Lanzavecchia and Federica Sallusto. These collaborations have further enriched his research and contributed to advancements in immunotherapy.

Conclusion

Roger Geiger's innovative work in T cell modulation exemplifies the impact of research on immunotherapy. His contributions are paving the way for new therapeutic strategies that could benefit many patients in the future.